Sugammadex Labatec 200 mg/2ml
Sugammadex Labatec 200 mg/2ml is a medicine authorised by Swissmedic under authorisation number 69239. The authorisation holder is Labatec Pharma SA. The medicinal product code is Antidotes and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 September 2023 and the authorisation is limited until 28 September 2028. ATC code V03AB35 places the medicine in the group All other therapeutic products.
| Authorisation number | 69239 |
|---|---|
| Name | Sugammadex Labatec 200 mg/2ml |
| Full name | Sugammadex Labatec 200 mg/2ml, solution injectable |
| Authorisation holder | Labatec Pharma SA |
| Medicinal product code | Antidotes |
| Dispensing category | B · Prescription only |
| ATC code | V03AB35 |
| First authorisation | 29 September 2023 |
| Authorisation validity | 28 September 2028 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Sugammadex Labatec 200 mg/2ml, solution injectable | B | 29 September 2023 |
| 2 | Sugammadex Labatec 500 mg/5ml, solution injectable | B | 29 September 2023 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
| 2 | 10 | Durchstechflasche(n) | V03AB35 | 15.01.0. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Sugammadex Labatec 200 mg/2ml authorised in Switzerland?
Yes. Sugammadex Labatec 200 mg/2ml is authorised by Swissmedic under authorisation number 69239, data as of 01 September 2026. The authorisation is limited until 28 September 2028.
Which dispensing category does Sugammadex Labatec 200 mg/2ml have?
Sugammadex Labatec 200 mg/2ml is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Sugammadex Labatec 200 mg/2ml?
The authorisation holder is Labatec Pharma SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.